T
HE remarkable adhesive and bonding action of the alkyl cyanoacrylate monomers is manifested in Eastman 910 (methyl 2-cyanoacrylate) and other homologues. The ideal adhesive for neurosurgery would have the following properties: 1 ) no toxicity to neural and vascular tissue, 2) strong and rapid bonding to bone dura, fascia, muscle, and synthetic substitutes, 3) ability to bond in the presence of blood and cerebrospinal fluid, 4) bacteriotoxicity, and 5) simplicity of application.
Critical review of all data on clinical and experimental studies with substituted cyanoacrylate tissue adhesive suggests both an optimistic as well as cautious approach to clinical application. At present, none of these materials is meant for routine surgical techniques. Physiological tissue adhesives are not physiological at all, but in many instances have positive properties that far outweigh the negative ones related to the trauma of implantation and histotoxicity. From our experience over a 5-year period, two conclusions are obvious: first, isobutyl 2-cyanoacrylate is the available compound that comes closest to meeting our criteria of an ideal tissue adhesive; and, second, the greatest use for a tissue adhesive in neurological surgery today is in the repair of cerebrospinal fluid fistulas.
Clinical Material
The initial use of isobutyl 2-cyanoacrylate (IBC) * in the repair of cerebrospinal fluid fistulas was reported in four patients operated on during 1965 at Walter Reed General Hospital. 3 In a footnote to that paper three additional cases were briefly mentioned. To this earlier communication we can now add 15 additional case reports, bringing the total number of cases to 22 over a 5-year period. Table 1 gives the preoperative, operative, and follow-up data in these cases. It has been our practice to use the tissue adhesive only in those cases where the use of sutures would be very difficult or impossible. Often a minute amount was used in conjunction with sutures to make the closure watertight. In more than half of the patients, the tissue adhesive was used after a previous attempt at repair of the fistula had failed. In fact, two The interval between onset of symptoms or accident and final repair of the fistula was delayed in many patients; Case 7 was operated on 13 years following the initial bout of meningitis. One patient, however, had his cerebrospinal fluid fistula repaired with IBC on the day of his accident.
In 1965 and 1966, IBC was used in conjunction with lyophilized cadaver dura; however, the dural defects in the last 13 patients have been repaired using a pericranial graft, except in Case 12, in which fascia lata was used.
In the 15 patients, there has been no recurrence of the cerebrospinal fluid leak or meningitis in any case. The one patient who died (Case 11) was operated on in a premoribund state. Surgery was undertaken in the face of a purulent meningitis because of a positive pressure pneumocephalus.
Technique
Since a vast majority of the cerebrospinal fluid fistulas presenting a real problem in surgical management are located in the midline of the frontal fossa, this is the area in which we have described its use.
A transcoronal skin incision is used. A generous-sized, low bifrontal osteoplastic bone flap is elevated (Fig. 1, insert) . The dura is opened transversely on each side of the superior sagittal sinus along the anterior margin of the craniotomy. After coagulation of the small frontopolar bridging veins, each frontal lobe is gently retracted in turn to expose the floor of the anterior fossa. If it becomes apparent that the lesion extends to the midline, the retraction is relaxed and attention again directed to the dural opening. The superior sagittal sinus is doubly ligated and transected. The falx is also incised to its free margin. Retraction can now be applied bifrontally to expose the area of fracture and dural defect (Fig. 1) . In the case illustrated, abnormalities are limited to the region of the right cribiform plate. The olfactory nerve is transected at the base of the bone and retracted to expose the dural margins (Fig. 2) . Because a watertight closure is possible without placing stitches in this paper-thin dura, extradural dissection is not necessary. The bone defect can be plugged with muscle and the pericranial graft placed over the dural defect. The brain and subarachnoid spaces are carefully protected with moist cotton strips. Beginning inferiorly the tissue adhesive is applied in minute amounts (Fig. 3 ) and the graft is held securely in place. As soon as the inferior margin is completely bonded, the free margin of the graft is elevated, and additional adhesive is added; the procedure is repeated until the entire graft is firmly bonded to the dural margins (Fig. 4) . The surgical field must be dry. Less than 1 minute is required for polymerization of the glue and firm adherence.
Discussion
We have found isobutyl 2-cyanoacrylate to possess many of the properties of an ideal tissue adhesive. This monomer has now been implanted in more than 30 of our patients, with follow-ups as long as 4 years, with no adverse effects. It should be emphasized that very minute quantities of the adhesive are used. Rarely is more than 1 cc of IBC necessary in any size of dural defect. Because this substance is mildly neurotoxic, 2,4 the glue must be kept from contact with cerebral tis- sue at all times during implantation of a dural graft. The brain is carefully shielded with cottonoid strips. Bonding occurs poorly or not at all in the presence of blood or cerebrospinal fluid. This monomer adheres well to dura, muscle, absorbable gelatin sponges, and suture material. It does not bond well to synthetic dural substitutes. It does adhere to bone but less well than to soft tissue. IBC is extremely simple to apply. It is prepared as both a liquid and aerosol spray. Because of our concern regarding histotoxicity only the liquid form has been used clinically. This form is supplied in a small squeeze tube which is presterilized and needs no mixing. After the seal is punctured, the material is squeezed out like toothpaste. The consistency is similar to water making spreading rapid and easy. Since a thin layer of IBC dries within seconds of application, grafts have to be placed quickly into position. This is a good feature, particularly where it is difficult to maintain a dry field. A graft can rarely be positioned without some drying. The graft-dural margins must often be reinforced with additional minute amounts of adhesive. The union thus formed is watertight and is strong enough to withstand the pressures along the base of the brain and the cribiform plate.
The outstanding neurosurgical application of tissue adhesives appears to be in the treatment of cerebrospinal fluid fistulas. A watertight closure of the dura is essential, yet occasionally in treating fistulas it is difficult or impossible to achieve watertight closure due to lack of space, lack of defined borders, insufficient substance to sew to, or inability to visualize a known site of cerebrospinal fluid leak. In our experience, recurrence of lead prior to the use of adhesives was all too frequent. 1,5 Although our present series is not large, it is remarkable that there has been no instance of recurrence of cerebrospinal fluid leak or meningitis. We realize that our follow-up is not long. These encouraging shortterm results, however, have led us to conclude that if, as we believe, IBC is a harmless substance when applied in the subdural space, it has a definite place in the neurosurgical armamentarium.
It must be reemphasized that clinical application of any tissue adhesive, including IBC, should not be routine. However, when confronted with a difficult, if not impossible, situation, the surgeon may find that glue offers a valuable alternative.
